References
- 1. Segawa H,Tsukayama DT, Kyle RF, Becker DA, Gustilo RB. Infection after total knee arthroplasty: aretrospective study of the treatment of eighty-one infections.J Bone and Joint Surgery[Am]. 1999; 81- A: 1434-45.
- 2. Goulet JA, Pellicci PM, Brause BD, Salvati EM. Prolonged suppression of infection in total hip arthroplasty. J Arthroplasty. 1988; 3(2): 109-16.
- 3. Canner GC, Steinberg ME, Heppenstall RB, Balderston R. The infected hip after total hip arthroplasty. J Bone Joint Surg Am. 1984; 66: 1393-99.
- 4. McDonald DJ, Fitzgerald RH Jr, Ilstrup DM. Twostage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg Am. 1989; 71: 828-34.
- 5. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hiparthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996; 78-A(4): 512-23.
- 6. Garvin KL, Hanssen AD. Current concepts review. Infection after total hip arthroplasty. Past, present, future. J Bone Joint Surg Am. 1995; 7-A(7): 1576-88.
- 7. Jamsen E, Sheng P, Halonen P, Lehto, et al. Spacer prostheses intwo-stage revision of infected knee arthroplasty. Int Orthop. 2006; 30: 257-61.
- 8. Dohmae Y, Bechtold JE, Sherman RE, Puno RM, Gustilo RB. Reduction in cement-bone interface shear strength between primary and revision arthroplasty. Clin Orthop Relat Res. 1988; 236: 21420.
- 9. Durbhakula CM, Czajka J, Fuchs MD, Uhl RL. Antibiotic loadedarticulating cement spacer in the 2- stageexchange of infected total knee arthroplasty. J Arthroplasty. 2004; 19: 768-74, 19768, 2004; [PubMed] [Cross Ref]
- 10. Haddad FS, Masri BA, Campbell D, Mc Graw RW, Bauchamp CP, Duncan CP. The PROSTALAC functional spacer in two stage revision for infected knee replacements. J Boneand Joint Surgery Br. 2000:82:807-12.82807 2000 [PubMed][Cross Ref]
- 11. Meani E, Romano CL, Crosby L, Hofmann G. Infection and local treatment in orthopaedic surgery. Berlin Heidelberg (GER): Springer-Verlag, 2007.
- 12. Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo RB. Infection after total knee arthroplasty: Aretrospective study of the treatment of eighty-one infections.J Bone and Joint Surgery[Am]. 1999; 81- A: 1434-45.
- 13. Bourne RB, Hunter GA, Rorabeck CH, Macnab JJ. A six-year follow-up of infected total hip replacements managed by Girdlestone’s arthroplasty. J Bone Joint Surg Br. 1984; 66: 340-3.
- 14. Younger ASE, Duncan CP, Masri BA, McGraw RW. The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty. 1997; 12(6): 615-23.
- 15. Younger ASE, Duncan CP, Masri BA. Treatment of infection with segmental bone loss in the proximal part of the femur in two stages with use of antibioticloaded interval prosthesis. J Bone Joint Surg Am. 1998; 80-A(1): 60-9.
- 16. Giovanni Pignatti,Shingo Nitta, Nicola Rani, Dante Dallari, Giacomo Sabbioni, Cesare Stagni and Armando Giunti: Two Stage Hip Revision in Periprosthetic Infection: Results of 41 Cases. J Bone and Joint Surgery[Am]2010;4: 1874-3250/10 2010 Bentham Open. 193-200.